1. Home
  2. INTS vs DFLI Comparison

INTS vs DFLI Comparison

Compare INTS & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • DFLI
  • Stock Information
  • Founded
  • INTS 2012
  • DFLI 2020
  • Country
  • INTS United States
  • DFLI United States
  • Employees
  • INTS N/A
  • DFLI N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • INTS Health Care
  • DFLI Technology
  • Exchange
  • INTS Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • INTS 12.2M
  • DFLI 14.5M
  • IPO Year
  • INTS 2023
  • DFLI N/A
  • Fundamental
  • Price
  • INTS $0.31
  • DFLI $1.11
  • Analyst Decision
  • INTS Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • INTS 4
  • DFLI 1
  • Target Price
  • INTS $4.50
  • DFLI $1.50
  • AVG Volume (30 Days)
  • INTS 5.0M
  • DFLI 69.5M
  • Earning Date
  • INTS 11-12-2025
  • DFLI 11-13-2025
  • Dividend Yield
  • INTS N/A
  • DFLI N/A
  • EPS Growth
  • INTS N/A
  • DFLI N/A
  • EPS
  • INTS N/A
  • DFLI N/A
  • Revenue
  • INTS N/A
  • DFLI $54,536,000.00
  • Revenue This Year
  • INTS N/A
  • DFLI $27.77
  • Revenue Next Year
  • INTS N/A
  • DFLI $42.02
  • P/E Ratio
  • INTS N/A
  • DFLI N/A
  • Revenue Growth
  • INTS N/A
  • DFLI 4.80
  • 52 Week Low
  • INTS $0.19
  • DFLI $0.15
  • 52 Week High
  • INTS $3.75
  • DFLI $5.78
  • Technical
  • Relative Strength Index (RSI)
  • INTS 64.31
  • DFLI 59.17
  • Support Level
  • INTS $0.27
  • DFLI $1.21
  • Resistance Level
  • INTS $0.30
  • DFLI $1.43
  • Average True Range (ATR)
  • INTS 0.03
  • DFLI 0.24
  • MACD
  • INTS 0.01
  • DFLI 0.06
  • Stochastic Oscillator
  • INTS 60.25
  • DFLI 41.13

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.

Share on Social Networks: